You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Vaginal Tactile Imager for Pelvic Floor Biomechanical Assessment

    SBC: ARTANN LABORATORIES, INC.            Topic: N

    Pelvic organ prolapse POP is a highly prevalent condition affecting over of women in the US during their lifetimes Urinary incontinence UI affects an estimated of women Both POP and UI are more common in women than in men and their prevalence is increased with age Some loss of utero vaginal support occurs in most adult women however the true etiology of prolapse and differences se ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  2. Precision Quality Check of Immunotherapeutics via Single Cell Cytokine Mapping

    SBC: ISOPLEXIS CORPORATION            Topic: 102

    Despite the demonstrated benefit of CD targeted CAR T immunotherapeutics two challenges remain to bringing the therapeutics to market The first key challenge is to reproducibly manufacture the therapy so that the cellsandapos cytokine mediated function acts in a predictably consistent fashion post manufacturing The second key challenge is to manage the cellandapos s adverse effect immuno to ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  3. A Toolkit for Pharmacotherapy of Dermally Administered Compounds

    SBC: CFD RESEARCH CORPORATION            Topic: FDA

    DESCRIPTION provided by applicant Delivery of therapeutic drugs via the dermal route is a promising alternative to oral or parenteral delivery routes Dermal drug delivery systems DS offer unique advantages which include controlled release over longer durations for steady absorption into the systemic circulation reduced systemic toxicity significant reduction in first pass effects and ga ...

    SBIR Phase I 2016 Department of Health and Human ServicesFood and Drug Administration
  4. Cervix monitor for risk assessment of spontaneous preterm delivery

    SBC: ADVANCED TACTILE IMAGING INC            Topic: NICHD

    Currently spontaneous preterm delivery SPTD is the leading global cause of infant mortality and morbidity In most countries the rate of preterm births has risen in recent decades and now represents the largest cause of neonatal death and the second largest direct cause of death in children under five Discovering how to lower the rate of this major complication of pregnancy should be one of t ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  5. Progenitors of nucleus pulposus cells for treating intervertebral disc degeneration

    SBC: INNOVATIVE ELEMENTS, LLC            Topic: NIAMS

    Summary Low back pain causes severe morbidity and imposes high socioeconomic burden Degeneration of the intervertebral disc IVD is one of the common causes for low back pain Cell therapy is an emerging solution to restore cellularity and functionality of the nucleus pulposus NP of the IVD with potential to reverse disc degeneration or regenerate the disc Due to poor availability neither ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  6. A Predictive In Vitro Model for Screening Personalized Responses to CFTR-directed Therapeutics

    SBC: CFD RESEARCH CORPORATION            Topic: NHLBI

    Abstract The objective of this study is to develop a novel predictive in vitro model for personalized responses to CFTR directed therapeutics This proposal responds to RFA HL Human Cellular Models for Predicting Individual Responses to Cystic Fibrosis Transmembrane Conductance Regulator Directed Therapeutics Cystic fibrosis CF is a life shortening genetic disease caused by loss of ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  7. Novel Ras inhibitor prodrug for colorectal cancer

    SBC: ADT Pharmaceuticals, LLC            Topic: 102

    DESCRIPTION provided by applicant Mutations in the ras family of genes were first identified in human cancer over years ago Such mutations result in the constitutive activation of one or more of three major Ras protein isoforms including H Ras N Ras or K Ras that mediate important signaling pathways leading to uncontrolled cell growth and tumor development Activating ras gene mutations ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  8. Automated zero lift device to reduce caregiver injury and support independent living

    SBC: Unique Mobility Devices LLC            Topic: N

    Abstract This SBIR application supports the development of a fall recovery and patient mobility medical device to reduce medical professional and caregiver injuries caused by lifting patients The SitAssist device is designed to recover a patient from a prone to sitting position or vice versa with minimal patient movement force and effort The device is designed both to assist the medical comm ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  9. Leveraging advanced clinical phenotyping to enhance problem lists and support value-based healthcare

    SBC: VMT, INC.            Topic: NLM

    Project Summary As United States healthcare seeks to address inconsistent quality and overwhelming cost data and technology have become central to all suggested approaches With newly available electronic health data and massive growth in processing power the hardest challenges in using clinical data are becoming clear Big data holds the potential to enable personalized patient care population ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  10. A Novel Glycosaminoglycan-Based Therapeutic for Chronic Rhinosinusitis

    SBC: GLYCOMIRA, LLC            Topic: NIAID

    PROJECT SUMMARY This proposal aims to develop a therapeutic capable of preventing and treating the severe sinus inflammation associated with chronic rhinosinusitis CRS CRS is a debilitating inflammatory disease of the sinuses that impacts over million Americans and substantially diminishes the quality of life and productivity of affected patients From to the total US health care ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government